PULSE BIOSCIENCES, INC. — Director's Dealing 2025

Jul 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-07-14

Reporting Person: Weber Steven (Principal Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-14	Stock Option (right to buy)	$16.03	A	55000	Acquired	2035-07-14	Common Stock (55000)	Direct

Footnotes

F1: Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to the Issuer's market capitalization ranging from $1.5 billion to $4.0 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.